Cyclo Therapeutics (CYTHW) Competitors $0.03 0.00 (0.00%) As of 03/26/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock CYTHW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Cyclo Therapeutics stock or one of its competitors? The main competitors of Cyclo Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Cyclo Therapeutics vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Cyclo Therapeutics (NASDAQ:CYTHW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, valuation and dividends. Does the media prefer CYTHW or ATNFW? In the previous week, Cyclo Therapeutics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score. Company Overall Sentiment Cyclo Therapeutics Neutral 180 Life Sciences Neutral Does the MarketBeat Community favor CYTHW or ATNFW? Cyclo Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCyclo TherapeuticsN/AN/A180 Life SciencesN/AN/A Which has stronger earnings & valuation, CYTHW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCyclo Therapeutics$870.73KN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is CYTHW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Cyclo TherapeuticsN/A N/A N/A 180 Life Sciences N/A N/A N/A SummaryCyclo Therapeutics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Remove Ads Get Cyclo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTHW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYTHW vs. The Competition Export to ExcelMetricCyclo TherapeuticsDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.21B$5.24B$7.07BDividend YieldN/A2.92%4.87%4.05%P/E RatioN/A4.2421.2017.47Price / SalesN/A513.87356.3585.24Price / CashN/A10.2538.1634.64Price / BookN/A6.236.233.79Net IncomeN/A$20.70B$3.20B$247.10M7 Day PerformanceN/A-3.71%-8.32%-7.32%1 Month PerformanceN/A-5.81%-3.36%-10.20%1 Year PerformanceN/A81.79%2.72%-7.41% Cyclo Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYTHWCyclo TherapeuticsN/A$0.03flatN/AN/A$0.00$870,725.000.009Gap DownATNFW180 Life SciencesN/A$0.01+5.3%N/A-18.8%$0.00N/A0.007Positive NewsGap DownHigh Trading VolumeLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.02-8.7%N/A-91.8%$0.00N/A0.002AIMDWAinosN/A$0.11-8.3%N/A+54.6%$0.00$20,729.000.0040Positive NewsALVOWAlvotechN/A$1.51-3.2%N/A-57.6%$0.00$391.87M0.004Positive NewsGap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/A-42.9%$0.00N/A0.0015BFRIWBiofronteraN/A$0.06-36.2%N/A+107.7%$0.00$37.32M0.0070Positive NewsGap DownBTMDWbioteN/A$0.06flatN/A-86.1%$0.00$197.19M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.10-1.8%N/A-91.6%$0.00N/A0.008Positive NewsGap DownCELUWCelularityN/A$0.04-14.7%N/A-15.6%$0.00$48.20M0.00220Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies ATNFW Competitors LBPSW Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors ACABW Competitors BFRIW Competitors BTMDW Competitors BCTXW Competitors CELUW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYTHW) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.